1. Home
  2. CRCT vs AURA Comparison

CRCT vs AURA Comparison

Compare CRCT & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cricut Inc.

CRCT

Cricut Inc.

HOLD

Current Price

$5.56

Market Cap

913.1M

Sector

Industrials

ML Signal

HOLD

Logo Aura Biosciences Inc.

AURA

Aura Biosciences Inc.

HOLD

Current Price

$7.71

Market Cap

797.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRCT
AURA
Founded
1969
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Wholesale Distributors
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
913.1M
797.5M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
CRCT
AURA
Price
$5.56
$7.71
Analyst Decision
Strong Sell
Strong Buy
Analyst Count
1
5
Target Price
$3.00
$20.00
AVG Volume (30 Days)
854.5K
687.8K
Earning Date
05-05-2026
05-08-2026
Dividend Yield
22.20%
N/A
EPS Growth
20.69
N/A
EPS
0.28
N/A
Revenue
$708,780,000.00
N/A
Revenue This Year
$0.08
N/A
Revenue Next Year
$0.98
N/A
P/E Ratio
$19.29
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.74
$4.73
52 Week High
$6.93
$9.54

Technical Indicators

Market Signals
Indicator
CRCT
AURA
Relative Strength Index (RSI) 57.35 55.46
Support Level $4.03 $6.49
Resistance Level $6.27 $9.54
Average True Range (ATR) 0.33 0.48
MACD -0.06 0.01
Stochastic Oscillator 50.65 54.41

Price Performance

Historical Comparison
CRCT
AURA

About CRCT Cricut Inc.

Cricut Inc designs and builds a creativity platform that enables users to turn ideas into professional-looking handmade goods. With its connected machines, design apps and accessories, and materials, the users create everything from personalized birthday cards, mugs and T-shirts to large-scale interior decorations. It has two segments including the Platform segment which derives revenue from monthly and annual subscription fees, purchases of digital content, and a minimal amount of the revenue allocated to unspecified future upgrades and enhancements related to the essential software and access to the Company's cloud-based services and Products segment which derives revenue from the sale of its connected machine hardware, and sale of craft, DIY, home decor products and extensions.

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: